down arrow

Hemant Surgical

Not Rated
  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0GYI01028
  • NSEID:
  • BSEID: 543916
  • View on BSE
INR
605.00
-8.55 (-1.39%)
BSENSE

Sep 25, 12:18 PM

BSE+NSE Vol: 4800

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Hemant Surgical Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
No of Months
12
12
Profit Before Tax
23.00
10.00
Adjustment
2.00
4.00
Changes In working Capital
-54.00
-8.00
Cash Flow after changes in Working Capital
-27.00
6.00
Cash Flow from Operating Activities
-32.00
4.00
Cash Flow from Investing Activities
-2.00
-30.00
Cash Flow from Financing Activities
69.00
21.00
Net Cash Inflow / Outflow
34.00
-3.00
Opening Cash & Cash Equivalents
9.00
13.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
Closing Cash & Cash Equivalent
43.00
9.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Hemant Surgical
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
23.59
-203.67
226.00
111.58%
Adjustment
2.92
138.12
-136.00
-97.89%
Changes In working Capital
-54.15
52.7
-106.00
-202.75%
Cash Flow after changes in Working Capital
-27.65
-12.85
-15.00
-115.18%
Cash Flow from Operating Activities
-32.04
-17.31
-15.00
-85.10%
Cash Flow from Investing Activities
-2.97
-1.13
-1.00
-162.83%
Cash Flow from Financing Activities
69.31
-0.44
69.00
15852.27%
Net Cash Inflow / Outflow
34.29
-18.89
52.00
281.52%
Opening Cash & Cash Equivalents
9.55
31.31
-22.00
-69.50%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
43.84
12.42
31.00
252.98%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -792.01% vs NA in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-32.04
4.63
-792.01%

Footer loading